Board MeetingOutcome of Board Meeting
IOL Chemicals & Pharma's board approved Q3 FY26 consolidated financial results.
IOL Chemicals and Pharmaceuticals LimitedIOLCP · Filed with the exchange
Revenue hit ₹580.39 Cr, Net Profit ₹20.58 Cr.
An interim dividend of ₹1/share was declared (Record Date: Feb 17). The company also formed a new UK subsidiary, IOL Pharmaxis UK Limited.
No comments yet. Be the first.